Nana Pogosova - Concepedia

Author

Nana Pogosova

National Medical Research Center of Cardiology ORCID

Also Known As

Andrzej Pajak, Andrzej Pająk, Anna Czlonkowska, Charles Mondo, G V Pogosova, G. V. Pogosova, G.V. Pogosova Pogosova, Goar-Nana V Pogosova, N Pogosova, N V Pogosova

271

Publications

17.9K

Citations

H-Index

Concepts

All Affiliations

National Medical Research Center of Cardiology Population Health Research Institute McMaster University Karolinska Institutet Hamilton Health Sciences

About

Nana Pogosova is an author at National Medical Research Center of Cardiology specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	9.8K
2	Public Health	14	17	7.2K
3	Diabetes	4	4	3.7K
4	Health Sciences	2	2	154
5	Social Sciences	1	1	47

Nana Pogosova

Publications

15.8K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, New England Journal of Medicine	2017	2.3K
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study Martin O’Donnell, Siu Lim Chin, Sumathy Rangarajan, The Lancet Cerebrovascular DiseaseCase-control StudyThrombosisStrokePrevalence	2016	2.1K
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries Kornelia Kotseva, David Wood, Dirk De Bacquer, European Journal of Preventive Cardiology	2015	985
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, European Journal of Preventive Cardiology	2019	887
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery Massimo Piepoli, Ugo Corrà, Stamatis Adamopoulos, European Journal of Preventive Cardiology Heart FailurePreventive CardiologyCardiovascular DiseasesCoronary Artery DiseaseAcute Myocardial Infarction	2012	587
Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey Birna Bjarnason‐Wehrens, Hannah McGee, Ann‐Dorthe Zwisler, European Journal of Cardiovascular Prevention & Rehabilitation	2010	497
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Gastroenterology Drug SafetyPatient SafetyPharmacologyProton Pump InhibitorsPharmacotherapy	2019	469

Page 1